Mitosis inhibitors in anticancer therapy: When blocking the exit becomes a solution.
Current microtubule-targeting agents (MTAs) remain amongst the most important antimitotic drugs used against a broad range of malignancies. By perturbing spindle assembly, MTAs activate the spindle assembly checkpoint (SAC), which induces mitotic arrest and subsequent apoptosis. However, besides tox...
Main Author: | |
---|---|
Format: | article |
Language: | eng |
Published: |
2018
|
Subjects: | |
Online Access: | http://hdl.handle.net/20.500.11816/2982 |
Country: | Portugal |
Oai: | oai:repositorio.cespu.pt:20.500.11816/2982 |